Ann: Quarter 4 Update, page-7

Hi mate, not a great deal there to analyse... great to see a trickle of revenues from Medihale, some broad statements about going forward with the partnerships & sales networks in place.

Of course it’s only an activities update so it’s not going to be full of details but I would like to see some firmer business planning, indications of how those revenues might grow and some forecasts on how quickly they might grow... maybe a well put together investor presentation is what we need.

The Fevertel side of the business... I think I may have commented last Qtr that it looked a little dead in the water and it still looks dead to me. Comments indicate that they will be re-assessing Fevertel during Q1 - so this looks like it might either be re-vamped into another incarnation or possibly abandoned?

Good to see the cash position is shored up, low cash burn, share price still reasonably well supported.